Jacob Asset Management of New York’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$352K Buy
50,260
+25,795
+105% +$238K 0.5% 49
2023
Q2
$208K Buy
24,465
+2,054
+9% +$17.1K 0.23% 57
2023
Q1
$205K Buy
22,411
+3,292
+17% +$42.1K 0.24% 57
2022
Q4
$218K Buy
19,119
+698
+4% +$10.3K 0.27% 53
2022
Q3
$314K Buy
18,421
+2,927
+19% +$62.8K 0.34% 48
2022
Q2
$333K Buy
15,494
+5,185
+50% +$144K 0.34% 50
2022
Q1
$381K Buy
10,309
+2,401
+30% +$93.6K 0.23% 60
2021
Q4
$360K Buy
7,908
+3,179
+67% +$166K 0.16% 65
2021
Q3
$300K Buy
4,729
+1,112
+31% +$84.7K 0.11% 74
2021
Q2
$331K Hold
3,617
0.11% 79
2021
Q1
$246K Hold
3,617
0.1% 75
2020
Q4
$262K Buy
+3,617
New +$210K 0.2% 58

Other funds holding CDNA

Jacob Asset Management of New York's CDNA Position: Q3 2023 in Review

Jacob Asset Management of New York increased its CareDx (CDNA) stake by 105% in Q3 2023, buying an estimated $238K and bringing the position to 50,260 shares worth $352K. The position accounts for 0.5% of the portfolio, ranked #49.

Jacob Asset Management of New York first reported a position in CDNA in Q4 2020 and has held it in 12 quarters since. The position peaked at $381K in Q1 2022. 150 funds tracked by Wall St. Rank hold CDNA as of Q3 2023.

  • Jacob Asset Management of New York held 50,260 shares of CareDx worth $352K as of Q3 2023.
  • Jacob Asset Management of New York bought 25,795 CareDx shares in Q3 2023, an estimated $238K.
  • CareDx made up 0.5% of Jacob Asset Management of New York's portfolio in Q3 2023, its #49 holding.
  • Jacob Asset Management of New York first reported a position in CareDx in Q4 2020 and has held it in 12 quarters since.
  • Jacob Asset Management of New York's CareDx position peaked at $381K in Q1 2022.
  • 150 funds tracked by Wall St. Rank held CareDx as of Q3 2023.

Based on Jacob Asset Management of New York's 13F filing for Q3 2023, filed 1 Nov 2023.